Polaryx Therapeutics (PLYX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Polaryx Therapeutics reported total assets of $5.17M and total liabilities of $605.00K. Shareholders' equity was $4.57M, down 3.1% from $4.71M a year earlier. Total debt stood at $0.00 against $5.14M in cash and short-term investments, a net cash position of $5.14M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Polaryx Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Polaryx Therapeutics, Inc. (PLYX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023
Period ending	Dec 2025	Dec 2024	Dec 2023
Current Assets
Cash and Cash Equivalents	5.14	4.62	0.00
Cash & Short-Term Investments	5.14	4.62	0.00
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.03	0.38	2.31
Total Current Assets	5.17	5.00	2.32
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00
Total Non-Current Assets	0.25	0.00	0.00
Total Assets	5.17	5.00	2.32
Current Liabilities
Accounts Payable	0.56	0.07	0.47
Short-Term Debt	0.00	0.00	0.13
Accrued Liabilities	0.04	0.09	0.09
Other Current Liabilities	0.14	0.22	0.44
Total Current Liabilities	0.61	0.29	1.04
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00
Deferred Tax Liabilities	0.25	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	0.25	0.00	0.00
Total Liabilities	0.61	0.29	1.04
Stockholders' Equity
Common Stock	0.01	0.00	0.00
Retained Earnings	-99.64	-90.65	-60.29
Additional Paid-in Capital	104.20	95.36	61.57
Shares Outstanding	47.34	47.34	47.34
Total Stockholders' Equity	4.57	4.71	1.28
Total Liabilities & Equity	5.17	5.00	2.32

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Polaryx Therapeutics Balance Sheet

How much debt does Polaryx Therapeutics have?

Polaryx Therapeutics had total debt of $0.00 as of Dec 31, 2025, against $5.14M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Polaryx Therapeutics's total assets?

Polaryx Therapeutics reported total assets of $5.17M as of Dec 31, 2025, up 3.4% from $5.00M a year earlier. Total liabilities were $605.00K.

What is Polaryx Therapeutics's shareholders' equity?

Polaryx Therapeutics's shareholders' equity was $4.57M as of Dec 31, 2025, or about $0.10 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition